ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Live Cell Microfluidic Encapsulation Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-22Z16053
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Live Cell Microfluidic Encapsulation Market Research Report 2023
BUY CHAPTERS

Global Live Cell Microfluidic Encapsulation Market Research Report 2025

Code: QYRE-Auto-22Z16053
Report
May 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ViaCyte Inc
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
Pharmacyte Biotech, Inc.
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd

Live Cell Microfluidic Encapsulation Market

The global market for Live Cell Microfluidic Encapsulation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Live Cell Microfluidic Encapsulation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Live Cell Microfluidic Encapsulation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Live Cell Microfluidic Encapsulation in Diabetes is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Live Cell Microfluidic Encapsulation include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Live Cell Microfluidic Encapsulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Cell Microfluidic Encapsulation.
The Live Cell Microfluidic Encapsulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Live Cell Microfluidic Encapsulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Cell Microfluidic Encapsulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Live Cell Microfluidic Encapsulation Market Report

Report Metric Details
Report Name Live Cell Microfluidic Encapsulation Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Live Cell Microfluidic Encapsulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Live Cell Microfluidic Encapsulation Market report?

Ans: The main players in the Live Cell Microfluidic Encapsulation Market are Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd

What are the Application segmentation covered in the Live Cell Microfluidic Encapsulation Market report?

Ans: The Applications covered in the Live Cell Microfluidic Encapsulation Market report are Diabetes, Cancer, Epilepsy, Parkinson, Others

What are the Type segmentation covered in the Live Cell Microfluidic Encapsulation Market report?

Ans: The Types covered in the Live Cell Microfluidic Encapsulation Market report are Alginate, Chitosan, Cellulose, Others

Recommended Reports

Microfluidic Technologies

Cell Culture Solutions

Encapsulation Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Live Cell Microfluidic Encapsulation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Alginate
1.2.3 Chitosan
1.2.4 Cellulose
1.2.5 Others
1.3 Market by Application
1.3.1 Global Live Cell Microfluidic Encapsulation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diabetes
1.3.3 Cancer
1.3.4 Epilepsy
1.3.5 Parkinson
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Live Cell Microfluidic Encapsulation Market Perspective (2020-2031)
2.2 Global Live Cell Microfluidic Encapsulation Growth Trends by Region
2.2.1 Global Live Cell Microfluidic Encapsulation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Live Cell Microfluidic Encapsulation Historic Market Size by Region (2020-2025)
2.2.3 Live Cell Microfluidic Encapsulation Forecasted Market Size by Region (2026-2031)
2.3 Live Cell Microfluidic Encapsulation Market Dynamics
2.3.1 Live Cell Microfluidic Encapsulation Industry Trends
2.3.2 Live Cell Microfluidic Encapsulation Market Drivers
2.3.3 Live Cell Microfluidic Encapsulation Market Challenges
2.3.4 Live Cell Microfluidic Encapsulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Live Cell Microfluidic Encapsulation Players by Revenue
3.1.1 Global Top Live Cell Microfluidic Encapsulation Players by Revenue (2020-2025)
3.1.2 Global Live Cell Microfluidic Encapsulation Revenue Market Share by Players (2020-2025)
3.2 Global Live Cell Microfluidic Encapsulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Live Cell Microfluidic Encapsulation Revenue
3.4 Global Live Cell Microfluidic Encapsulation Market Concentration Ratio
3.4.1 Global Live Cell Microfluidic Encapsulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Live Cell Microfluidic Encapsulation Revenue in 2024
3.5 Global Key Players of Live Cell Microfluidic Encapsulation Head office and Area Served
3.6 Global Key Players of Live Cell Microfluidic Encapsulation, Product and Application
3.7 Global Key Players of Live Cell Microfluidic Encapsulation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Live Cell Microfluidic Encapsulation Breakdown Data by Type
4.1 Global Live Cell Microfluidic Encapsulation Historic Market Size by Type (2020-2025)
4.2 Global Live Cell Microfluidic Encapsulation Forecasted Market Size by Type (2026-2031)
5 Live Cell Microfluidic Encapsulation Breakdown Data by Application
5.1 Global Live Cell Microfluidic Encapsulation Historic Market Size by Application (2020-2025)
5.2 Global Live Cell Microfluidic Encapsulation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Live Cell Microfluidic Encapsulation Market Size (2020-2031)
6.2 North America Live Cell Microfluidic Encapsulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Live Cell Microfluidic Encapsulation Market Size by Country (2020-2025)
6.4 North America Live Cell Microfluidic Encapsulation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Live Cell Microfluidic Encapsulation Market Size (2020-2031)
7.2 Europe Live Cell Microfluidic Encapsulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Live Cell Microfluidic Encapsulation Market Size by Country (2020-2025)
7.4 Europe Live Cell Microfluidic Encapsulation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Live Cell Microfluidic Encapsulation Market Size (2020-2031)
8.2 Asia-Pacific Live Cell Microfluidic Encapsulation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Live Cell Microfluidic Encapsulation Market Size by Region (2020-2025)
8.4 Asia-Pacific Live Cell Microfluidic Encapsulation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Live Cell Microfluidic Encapsulation Market Size (2020-2031)
9.2 Latin America Live Cell Microfluidic Encapsulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Live Cell Microfluidic Encapsulation Market Size by Country (2020-2025)
9.4 Latin America Live Cell Microfluidic Encapsulation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Live Cell Microfluidic Encapsulation Market Size (2020-2031)
10.2 Middle East & Africa Live Cell Microfluidic Encapsulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Live Cell Microfluidic Encapsulation Market Size by Country (2020-2025)
10.4 Middle East & Africa Live Cell Microfluidic Encapsulation Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Viacyte, Inc.
11.1.1 Viacyte, Inc. Company Details
11.1.2 Viacyte, Inc. Business Overview
11.1.3 Viacyte, Inc. Live Cell Microfluidic Encapsulation Introduction
11.1.4 Viacyte, Inc. Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025)
11.1.5 Viacyte, Inc. Recent Development
11.2 Living Cell Technologies Ltd.
11.2.1 Living Cell Technologies Ltd. Company Details
11.2.2 Living Cell Technologies Ltd. Business Overview
11.2.3 Living Cell Technologies Ltd. Live Cell Microfluidic Encapsulation Introduction
11.2.4 Living Cell Technologies Ltd. Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025)
11.2.5 Living Cell Technologies Ltd. Recent Development
11.3 Sigilon Therapeutics, Inc
11.3.1 Sigilon Therapeutics, Inc Company Details
11.3.2 Sigilon Therapeutics, Inc Business Overview
11.3.3 Sigilon Therapeutics, Inc Live Cell Microfluidic Encapsulation Introduction
11.3.4 Sigilon Therapeutics, Inc Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025)
11.3.5 Sigilon Therapeutics, Inc Recent Development
11.4 Sernova Corporation
11.4.1 Sernova Corporation Company Details
11.4.2 Sernova Corporation Business Overview
11.4.3 Sernova Corporation Live Cell Microfluidic Encapsulation Introduction
11.4.4 Sernova Corporation Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025)
11.4.5 Sernova Corporation Recent Development
11.5 PharmaCyte Biotech Inc
11.5.1 PharmaCyte Biotech Inc Company Details
11.5.2 PharmaCyte Biotech Inc Business Overview
11.5.3 PharmaCyte Biotech Inc Live Cell Microfluidic Encapsulation Introduction
11.5.4 PharmaCyte Biotech Inc Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025)
11.5.5 PharmaCyte Biotech Inc Recent Development
11.6 Gloriana Therapeutics
11.6.1 Gloriana Therapeutics Company Details
11.6.2 Gloriana Therapeutics Business Overview
11.6.3 Gloriana Therapeutics Live Cell Microfluidic Encapsulation Introduction
11.6.4 Gloriana Therapeutics Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025)
11.6.5 Gloriana Therapeutics Recent Development
11.7 Kadimastem
11.7.1 Kadimastem Company Details
11.7.2 Kadimastem Business Overview
11.7.3 Kadimastem Live Cell Microfluidic Encapsulation Introduction
11.7.4 Kadimastem Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025)
11.7.5 Kadimastem Recent Development
11.8 Beta-O2 Technologies, Inc.
11.8.1 Beta-O2 Technologies, Inc. Company Details
11.8.2 Beta-O2 Technologies, Inc. Business Overview
11.8.3 Beta-O2 Technologies, Inc. Live Cell Microfluidic Encapsulation Introduction
11.8.4 Beta-O2 Technologies, Inc. Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025)
11.8.5 Beta-O2 Technologies, Inc. Recent Development
11.9 Altucell, Inc.
11.9.1 Altucell, Inc. Company Details
11.9.2 Altucell, Inc. Business Overview
11.9.3 Altucell, Inc. Live Cell Microfluidic Encapsulation Introduction
11.9.4 Altucell, Inc. Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025)
11.9.5 Altucell, Inc. Recent Development
11.10 Diatranz Otsuka Ltd
11.10.1 Diatranz Otsuka Ltd Company Details
11.10.2 Diatranz Otsuka Ltd Business Overview
11.10.3 Diatranz Otsuka Ltd Live Cell Microfluidic Encapsulation Introduction
11.10.4 Diatranz Otsuka Ltd Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025)
11.10.5 Diatranz Otsuka Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
ViaCyte Inc
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
Pharmacyte Biotech, Inc.
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd
List of Tables
 Table 1. Global Live Cell Microfluidic Encapsulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Alginate
 Table 3. Key Players of Chitosan
 Table 4. Key Players of Cellulose
 Table 5. Key Players of Others
 Table 6. Global Live Cell Microfluidic Encapsulation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Live Cell Microfluidic Encapsulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Live Cell Microfluidic Encapsulation Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Live Cell Microfluidic Encapsulation Market Share by Region (2020-2025)
 Table 10. Global Live Cell Microfluidic Encapsulation Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Live Cell Microfluidic Encapsulation Market Share by Region (2026-2031)
 Table 12. Live Cell Microfluidic Encapsulation Market Trends
 Table 13. Live Cell Microfluidic Encapsulation Market Drivers
 Table 14. Live Cell Microfluidic Encapsulation Market Challenges
 Table 15. Live Cell Microfluidic Encapsulation Market Restraints
 Table 16. Global Live Cell Microfluidic Encapsulation Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Live Cell Microfluidic Encapsulation Market Share by Players (2020-2025)
 Table 18. Global Top Live Cell Microfluidic Encapsulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Cell Microfluidic Encapsulation as of 2024)
 Table 19. Ranking of Global Top Live Cell Microfluidic Encapsulation Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Live Cell Microfluidic Encapsulation Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Live Cell Microfluidic Encapsulation, Headquarters and Area Served
 Table 22. Global Key Players of Live Cell Microfluidic Encapsulation, Product and Application
 Table 23. Global Key Players of Live Cell Microfluidic Encapsulation, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Live Cell Microfluidic Encapsulation Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Live Cell Microfluidic Encapsulation Revenue Market Share by Type (2020-2025)
 Table 27. Global Live Cell Microfluidic Encapsulation Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Live Cell Microfluidic Encapsulation Revenue Market Share by Type (2026-2031)
 Table 29. Global Live Cell Microfluidic Encapsulation Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Live Cell Microfluidic Encapsulation Revenue Market Share by Application (2020-2025)
 Table 31. Global Live Cell Microfluidic Encapsulation Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Live Cell Microfluidic Encapsulation Revenue Market Share by Application (2026-2031)
 Table 33. North America Live Cell Microfluidic Encapsulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Live Cell Microfluidic Encapsulation Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Live Cell Microfluidic Encapsulation Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Live Cell Microfluidic Encapsulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Live Cell Microfluidic Encapsulation Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Live Cell Microfluidic Encapsulation Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Live Cell Microfluidic Encapsulation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Live Cell Microfluidic Encapsulation Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Live Cell Microfluidic Encapsulation Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Live Cell Microfluidic Encapsulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Live Cell Microfluidic Encapsulation Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Live Cell Microfluidic Encapsulation Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Live Cell Microfluidic Encapsulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Live Cell Microfluidic Encapsulation Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Live Cell Microfluidic Encapsulation Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Viacyte, Inc. Company Details
 Table 49. Viacyte, Inc. Business Overview
 Table 50. Viacyte, Inc. Live Cell Microfluidic Encapsulation Product
 Table 51. Viacyte, Inc. Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025) & (US$ Million)
 Table 52. Viacyte, Inc. Recent Development
 Table 53. Living Cell Technologies Ltd. Company Details
 Table 54. Living Cell Technologies Ltd. Business Overview
 Table 55. Living Cell Technologies Ltd. Live Cell Microfluidic Encapsulation Product
 Table 56. Living Cell Technologies Ltd. Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025) & (US$ Million)
 Table 57. Living Cell Technologies Ltd. Recent Development
 Table 58. Sigilon Therapeutics, Inc Company Details
 Table 59. Sigilon Therapeutics, Inc Business Overview
 Table 60. Sigilon Therapeutics, Inc Live Cell Microfluidic Encapsulation Product
 Table 61. Sigilon Therapeutics, Inc Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025) & (US$ Million)
 Table 62. Sigilon Therapeutics, Inc Recent Development
 Table 63. Sernova Corporation Company Details
 Table 64. Sernova Corporation Business Overview
 Table 65. Sernova Corporation Live Cell Microfluidic Encapsulation Product
 Table 66. Sernova Corporation Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025) & (US$ Million)
 Table 67. Sernova Corporation Recent Development
 Table 68. PharmaCyte Biotech Inc Company Details
 Table 69. PharmaCyte Biotech Inc Business Overview
 Table 70. PharmaCyte Biotech Inc Live Cell Microfluidic Encapsulation Product
 Table 71. PharmaCyte Biotech Inc Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025) & (US$ Million)
 Table 72. PharmaCyte Biotech Inc Recent Development
 Table 73. Gloriana Therapeutics Company Details
 Table 74. Gloriana Therapeutics Business Overview
 Table 75. Gloriana Therapeutics Live Cell Microfluidic Encapsulation Product
 Table 76. Gloriana Therapeutics Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025) & (US$ Million)
 Table 77. Gloriana Therapeutics Recent Development
 Table 78. Kadimastem Company Details
 Table 79. Kadimastem Business Overview
 Table 80. Kadimastem Live Cell Microfluidic Encapsulation Product
 Table 81. Kadimastem Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025) & (US$ Million)
 Table 82. Kadimastem Recent Development
 Table 83. Beta-O2 Technologies, Inc. Company Details
 Table 84. Beta-O2 Technologies, Inc. Business Overview
 Table 85. Beta-O2 Technologies, Inc. Live Cell Microfluidic Encapsulation Product
 Table 86. Beta-O2 Technologies, Inc. Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025) & (US$ Million)
 Table 87. Beta-O2 Technologies, Inc. Recent Development
 Table 88. Altucell, Inc. Company Details
 Table 89. Altucell, Inc. Business Overview
 Table 90. Altucell, Inc. Live Cell Microfluidic Encapsulation Product
 Table 91. Altucell, Inc. Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025) & (US$ Million)
 Table 92. Altucell, Inc. Recent Development
 Table 93. Diatranz Otsuka Ltd Company Details
 Table 94. Diatranz Otsuka Ltd Business Overview
 Table 95. Diatranz Otsuka Ltd Live Cell Microfluidic Encapsulation Product
 Table 96. Diatranz Otsuka Ltd Revenue in Live Cell Microfluidic Encapsulation Business (2020-2025) & (US$ Million)
 Table 97. Diatranz Otsuka Ltd Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Live Cell Microfluidic Encapsulation Picture
 Figure 2. Global Live Cell Microfluidic Encapsulation Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Live Cell Microfluidic Encapsulation Market Share by Type: 2024 VS 2031
 Figure 4. Alginate Features
 Figure 5. Chitosan Features
 Figure 6. Cellulose Features
 Figure 7. Others Features
 Figure 8. Global Live Cell Microfluidic Encapsulation Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Live Cell Microfluidic Encapsulation Market Share by Application: 2024 VS 2031
 Figure 10. Diabetes Case Studies
 Figure 11. Cancer Case Studies
 Figure 12. Epilepsy Case Studies
 Figure 13. Parkinson Case Studies
 Figure 14. Others Case Studies
 Figure 15. Live Cell Microfluidic Encapsulation Report Years Considered
 Figure 16. Global Live Cell Microfluidic Encapsulation Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Live Cell Microfluidic Encapsulation Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Live Cell Microfluidic Encapsulation Market Share by Region: 2024 VS 2031
 Figure 19. Global Live Cell Microfluidic Encapsulation Market Share by Players in 2024
 Figure 20. Global Top Live Cell Microfluidic Encapsulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Cell Microfluidic Encapsulation as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Live Cell Microfluidic Encapsulation Revenue in 2024
 Figure 22. North America Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Live Cell Microfluidic Encapsulation Market Share by Country (2020-2031)
 Figure 24. United States Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Live Cell Microfluidic Encapsulation Market Share by Country (2020-2031)
 Figure 28. Germany Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Live Cell Microfluidic Encapsulation Market Share by Region (2020-2031)
 Figure 36. China Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Live Cell Microfluidic Encapsulation Market Share by Country (2020-2031)
 Figure 44. Mexico Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Live Cell Microfluidic Encapsulation Market Share by Country (2020-2031)
 Figure 48. Turkey Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Live Cell Microfluidic Encapsulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Viacyte, Inc. Revenue Growth Rate in Live Cell Microfluidic Encapsulation Business (2020-2025)
 Figure 52. Living Cell Technologies Ltd. Revenue Growth Rate in Live Cell Microfluidic Encapsulation Business (2020-2025)
 Figure 53. Sigilon Therapeutics, Inc Revenue Growth Rate in Live Cell Microfluidic Encapsulation Business (2020-2025)
 Figure 54. Sernova Corporation Revenue Growth Rate in Live Cell Microfluidic Encapsulation Business (2020-2025)
 Figure 55. PharmaCyte Biotech Inc Revenue Growth Rate in Live Cell Microfluidic Encapsulation Business (2020-2025)
 Figure 56. Gloriana Therapeutics Revenue Growth Rate in Live Cell Microfluidic Encapsulation Business (2020-2025)
 Figure 57. Kadimastem Revenue Growth Rate in Live Cell Microfluidic Encapsulation Business (2020-2025)
 Figure 58. Beta-O2 Technologies, Inc. Revenue Growth Rate in Live Cell Microfluidic Encapsulation Business (2020-2025)
 Figure 59. Altucell, Inc. Revenue Growth Rate in Live Cell Microfluidic Encapsulation Business (2020-2025)
 Figure 60. Diatranz Otsuka Ltd Revenue Growth Rate in Live Cell Microfluidic Encapsulation Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Live Cell 3D Encapsulation Market Research Report 2024
Global 3D Microfluidic Cell Culture Market Research Report 2025
Global Microfluidics based 3D Cell Culture Market Research Report 2025
Global Microencapsulation Service Market Research Report 2024
Global Live Cell Encapsulation Market Research Report 2024
Global Microfluidic Chip Holder Market Research Report 2025
Global Microfluidic Technology Market Research Report 2024
Global Micro and Nano Encapsulation Market Research Report 2024
Global Electronic Encapsulant Market Research Report 2025
Global Microfluidic Consumables Market Research Report 2024
Global Microfluidic Biosensors Market Research Report 2025
Global Microfluidic Reservoir Market Research Report 2025
Global Ready to go Microfluidic Chips Market Research Report 2024
Global Encapsulators Market Research Report 2025
Global Microfluidic Single Cell Isolation Chip Market Research Report 2024
Global Live Cell Imaging Consumables Market Research Report 2024
Global Microfluidic Channel Chip Market Research Report 2024
Global Microfluidic Sensors Market Research Report 2025
Global 3D Microfluidic Organ Chip Market Research Report 2025
Global Live Cell Imaging Microscopy System Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions